Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating three dose levels of BAY1817080 versus placebo in patients with chronic cough has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• BAY1817080

Snippet

Sponsor: Bayer | Conditions: Refractory and/or Unexplained Chronic Cough | Phase 2 | Status: COMPLETED | Results posted: 2022-08-18